![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BOLDER BIOTECHNOLOGY RECEIVES NIH GRANT
BOLDER BIOTECHNOLOGY RECEIVES NIH GRANT
Bolder BioTechnology has been awarded a grant for more than $300,000 from NIH. The grant will be used to develop the company's proprietary long-acting growth hormone product. The product is being analyzed as a potential treatment for growth hormone deficiency, short stature in children and HIV-related wasting.
Denver Business Journal (http://www.bizjournals.com/denver/stories/2005/01/10/daily35.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct